Melanóma: vizsgálatok itt: Horvátország

1 trial · From EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

• 1. fázisTaking people
  A Double-Blind, Randomized, Three-arm, Active-Controlled, Parallel-Group, Phase 1 Study Evaluating Pharmacokinetic Similarity of Three Formulations of Pembrolizumab (CT-P51, EU-approved Keytruda, and US-licensed Keytruda) as Adjuvant Therapy in Patients with Completely Resected Stage IIB, IIC, and III Melanoma

  Where

  Rijeka

  Életkor

  18 év and over

  People

  83 worldwide

  Run by

  Celltrion Inc.

  See details and how to join2023-510017-26-00 · EU 2023-510017-26-00